HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Representative cancer-associated U2AF2 mutations alter RNA interactions and splicing.

Abstract
High-throughput sequencing of hematologic malignancies and other cancers has revealed recurrent mis-sense mutations of genes encoding pre-mRNA splicing factors. The essential splicing factor U2AF2 recognizes a polypyrimidine-tract splice-site signal and initiates spliceosome assembly. Here, we investigate representative, acquired U2AF2 mutations, namely N196K or G301D amino acid substitutions associated with leukemia or solid tumors, respectively. We determined crystal structures of the wild-type (WT) compared with N196K- or G301D-substituted U2AF2 proteins, each bound to a prototypical AdML polypyrimidine tract, at 1.5, 1.4, or 1.7 Å resolutions. The N196K residue appears to stabilize the open conformation of U2AF2 with an inter-RNA recognition motif hydrogen bond, in agreement with an increased apparent RNA-binding affinity of the N196K-substituted protein. The G301D residue remains in a similar position as the WT residue, where unfavorable proximity to the RNA phosphodiester could explain the decreased RNA-binding affinity of the G301D-substituted protein. We found that expression of the G301D-substituted U2AF2 protein reduces splicing of a minigene transcript carrying prototypical splice sites. We further show that expression of either N196K- or G301D-substituted U2AF2 can subtly alter splicing of representative endogenous transcripts, despite the presence of endogenous, WT U2AF2 such as would be present in cancer cells. Altogether, our results demonstrate that acquired U2AF2 mutations such as N196K and G301D are capable of dysregulating gene expression for neoplastic transformation.
AuthorsDebanjana Maji, Eliezra Glasser, Steven Henderson, Justin Galardi, Mary J Pulvino, Jermaine L Jenkins, Clara L Kielkopf
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 295 Issue 50 Pg. 17148-17157 (12 11 2020) ISSN: 1083-351X [Electronic] United States
PMID33020180 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© 2020 Maji et al.
Chemical References
  • Neoplasm Proteins
  • RNA, Neoplasm
  • Splicing Factor U2AF
  • U2AF2 protein, human
Topics
  • Amino Acid Motifs
  • Amino Acid Substitution
  • Humans
  • Mutation, Missense
  • Neoplasm Proteins (chemistry, genetics, metabolism)
  • Neoplasms (chemistry, genetics, metabolism)
  • RNA Splicing
  • RNA, Neoplasm (chemistry, genetics, metabolism)
  • Splicing Factor U2AF (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: